Company PHARMAGEST INTER. Euronext Paris
Equities
FR0000077687
IT Services & Consulting
End-of-day quote
Other stock markets
|
||
- EUR | - |
05-08 | Equasens: sales down 5% in Q1 | CF |
04-02 | Equasens : RNPG virtually stable in 2023 | CF |
Business Summary
- pharmacy software publishing and integration (74%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;
- publishing of IT solutions for health and medical/social establishments (14.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);
- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).
Net sales are distributed geographically as follows: France (89.7%), Italy (5.4%), Belgium (2.9%), Germany (1%), the United Kingdom (0.8%) and Ireland (0.2%).
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmagest
74.0
%
| 156 | 73.0 % | 163 | 74.0 % | +4.11% |
Axigate Link
14.2
%
| 33 | 15.2 % | 31 | 14.2 % | -4.56% |
Others
11.8
%
| 25 | 11.8 % | 26 | 11.8 % | +3.09% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
89.7
%
| 194 | 90.9 % | 197 | 89.7 % | +1.37% |
Italy
5.4
%
| 10 | 4.9 % | 12 | 5.4 % | +14.14% |
Belgium
2.9
%
| 6 | 2.6 % | 6 | 2.9 % | +13.52% |
Germany
1.0
%
| 2 | 0.8 % | 2 | 1.0 % | +33.97% |
United Kingdom
0.8
%
| 2 | 0.7 % | 2 | 0.8 % | +8.48% |
Ireland
0.2
%
| 0 | 0.1 % | 0 | 0.2 % | +61.73% |
Luxembourg
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | -41.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 31/12/90 | |
Thierry Chapusot
FOU | Founder | 65 | 24/01/96 |
Director of Finance/CFO | - | 31/12/22 | |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/18 |
Director/Board Member | 53 | 28/06/20 | |
Director/Board Member | 59 | 31/12/99 | |
Sabrina Gharbi
HRO | Human Resources Officer | - | 31/12/18 |
Erwan Salque
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Liza Natan
PRN | Corporate Officer/Principal | 50 | 31/12/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 24/01/96 |
Director/Board Member | 46 | 26/06/17 | |
Director/Board Member | 59 | 31/12/99 | |
Daniel Antoine
BRD | Director/Board Member | 72 | 31/12/01 |
Anne Lhote
BRD | Director/Board Member | 55 | 15/06/11 |
Chief Executive Officer | 55 | 31/12/90 | |
François Jacquel
BRD | Director/Board Member | 65 | 31/12/10 |
Emilie Lecomte
BRD | Director/Board Member | 45 | 26/06/17 |
Director/Board Member | 72 | 25/06/15 | |
Director/Board Member | 53 | 28/06/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,174,125 | 4,921,426 ( 32.43 %) | 142,890 ( 0.9417 %) | 32.43 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
EQUASENS 0.94% | 142,428 | 0.94% | 7,891,081 $ |
Company contact information
Equasens
5, Allée de Saint-Cloud Technopole de Nancy Brabois
54600, Villers-lès-Nancy
+33 3 83 15 95 95
http://equasens.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.62% | 196B | |
+3.74% | 172B | |
+1.66% | 156B | |
+5.23% | 99.43B | |
+10.96% | 80.17B | |
+24.53% | 75.89B | |
-8.05% | 70.99B | |
-21.67% | 52.69B | |
-10.40% | 42.62B |
- Stock Market
- Equities
- EQS Stock
- Stock
- Company PHARMAGEST INTER.